Thomas Carella Joins Warburg Pincus as Managing Director

04:06 EDT 19 Oct 2016 | PR Newswire

NEW YORK, Oct. 19, 2016 /PRNewswire/ -- Warburg Pincus, a leading global private equity firm focused on growth investing, today announced the appointment of Thomas ("TJ") Carella as a Managing Director in the Healthcare and Consumer group.  Mr. Carella joins from Goldman Sachs, where he was a Managing Director in its Merchant Banking Division and global head of the division's private equity activities in the healthcare sector.  At Warburg Pincus, he will identify, evaluate and execute investments in the healthcare industry, as well as work with the firm's current healthcare portfolio.

During Mr. Carella's tenure at Goldman Sachs, he led a number of investments in healthcare services, healthcare IT and life sciences, and worked in the New York, London and Milan offices.  Earlier in his career, Mr. Carella also co-founded and served as Chief Executive Officer of a software services business. 

"TJ has extensive experience in healthcare investing and brings tremendous acumen and expertise both to the firm and to our portfolio company management teams," said In Seon Hwang, Managing Director and Head of the Healthcare and Consumer group at Warburg Pincus. "His leadership, demonstrated track record and strong network of industry relationships will be invaluable to growing our global healthcare franchise." 

Mr. Carella commented, "Warburg Pincus is a leading growth investor in the healthcare industry globally.  I look forward to leading new and impactful investments in the sector and assisting the team in building value across the portfolio."  

Mr. Carella received a BA from Harvard College and an MBA from Harvard Business School.

About Warburg Pincus  Warburg Pincus LLC is a leading global private equity firm focused on growth investing. The firm has more than $40 billion in private equity assets under management. The firm's active portfolio of more than 120 companies is highly diversified by stage, sector and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Founded in 1966, Warburg Pincus has raised 15 private equity funds, which have invested more than $58 billion in over 760 companies in more than 40 countries.  The firm's current and past healthcare investments have included Bausch + Lomb, China Biologic Partners (CPBO), Coventry Health Care, Helix, Lepu Medical, Wright Medical and Zentiva.

The firm is headquartered in New York with offices in Amsterdam, Beijing, Hong Kong, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai and Singapore. For more information please visit

Contact:Mary Zimmerman / Christopher Beattie
(212) 878-9201

To view the original version on PR Newswire, visit:

SOURCE Warburg Pincus


More From BioPortfolio on "Thomas Carella Joins Warburg Pincus as Managing Director"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...